Enjoy complimentary customisation on priority with our Enterprise License!
The montelukast sodium market size is forecast to increase by USD 1.34 billion at a CAGR of 4.5% between 2023 and 2028. Montelukast sodium, a leukotriene modifier, has been a popular treatment option for asthma and other noncommunicable diseases (NCDs), particularly chronic respiratory diseases. The market is witnessing significant growth due to the increasing demand for effective asthma medications. Furthermore, patient assistance initiatives by governments and advocacy groups are contributing to the expansion of this market. However, challenges persist in the form of complexities in screening and diagnosis, which hinder timely intervention and treatment. Montelukast sodium's dosage form, which is available in oral tablet and oral solution, offers convenience and flexibility for patients, making it a preferred choice for managing asthma symptoms. As the prevalence of asthma and other chronic respiratory diseases continues to rise, the market is expected to grow steadily, providing opportunities for stakeholders in the healthcare industry.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.